Weld, E.D., Beattie, T., Moodley, J., Mapendere, M., Salles, I., Solans, B.P., Nonyane, B.A., Wiesner, L., Nielson, T., Edward, V.A. and Chihota, V., 2025. Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial. The Lancet HIV.
Garrett, N., Tapley, A., Hudson, A., Dadabhai, S., Zhang, B., Mgodi, N.M., Andriesen, J., Takalani, A., Fisher, L.H., Kee, J.J. and Magaret, C.A., 2025. Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study. EClinicalMedicine, 80.
Chihota, V., Gombe, M., Gupta, A., Salazar-Austin, N., Ryckman, T., Hoffmann, C.J., LaCourse, S., Mathad, J.S., Mave, V., Dooley, K.E. and Chaisson, R.E., 2024. Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review. Drugs, pp.1-21.
Fargnoli, V., Hanh, H.T.M., Hoang, L.N., Mahesh, A., Mqedlana-Ntombela, N., Xavier, J., Kohli, M., Velen, K. and Shilton, S., 2025. “Time to Change”: To What Extent Could Non-Sputum Sampling Accelerate the Fight Against Tuberculosis—A Qualitative Study Among End-Users. Tropical Medicine and Infectious Disease, 10(2), p.44.
Nguenha, D., Ndebele, F., Saavedra, B., Mambuque, E., Acácio, S., Cárdenas, V., Chihota, V., Grant, A., Yimer, G., Fielding, K. and Cobelens, F., 2025. BMI as a predictor of progression from TB infection to active TB in PLHIV. The International Journal of Tuberculosis and Lung Disease, 29(2), pp.54-59.
Sumner, T., Clark, R.A., Prys-Jones, T.O., Bakker, R., Churchyard, G. and White, R.G., 2022. The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa. AIDS, pp.10-1097.
Mapamba, D.A., Sabi, I., Lalashowi, J., Sauli, E., Buza, J., Olomi, W., Mtafya, B., Kibona, M., Bakuli, A., Rachow, A. and Velen, K., 2025. N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis. Journal of Infection, 90(2), p.106379.
Wand, H., Reddy, T., Moodley, J., Naidoo, S. and Ramjee, G., 2025. Review of Impact of Risk Reduction Sessions on Sexual Behaviors in HIV Prevention Trials: Insights from Africa. Archives of Sexual Behavior, pp.1-11.
